A Prospective Observational Study on Impact of Comorbidities in Patients with COVID-19 Infection
Keywords:Severe acute respiratory syndrome corona-virus 2 (SARS - COV-2), COVID-19, Comorbidities, Mortality, Hypertension, Diabetes.
A novel human Coronavirus severe acute respiratory syndrome Corona-virus 2 (SARS- Cov-2), pandemic has spread rapidly around the globe morbidity and mortality. Co-existence of Comorbidities with COVID-19 are more likely to develop a more severe cause and progression of the disease. Objectives: To asses the impact of Comorbidities in covid-19 infected patients. Materials and Methods: The study was carried at kR Hospital, Mysuru, Karnataka from April 2021 to June 2021. A total of 168 patients were enrolled in the study as and exclusion criteria. Patient’s data were collected using data collection forms, Patient /patient take cares interview, treatment chart review. Results: Most of the cases were male (69.6%) and in the age group of 40-59 years (39.3%) with a median age of 48 years (IQR – 33.55), One thirty-four patients had at least one comorbidity and most common among them were Hypertension (23.2%) and Diabetes (9.5%), The mortality rate was 11.3% and significantly higher proportion of patients with comorbidities died compared to those with none. Conclusion: Presence of comorbidities is associated with a poor outcome and are at a greater risk of dying from COVID-19 when compared to that of patients without Comorbidities.
How to Cite
JCRAM and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with firstname.lastname@example.org